Tyan F. Thomas
Research Subjects
Tyan F. Thomas has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Diane E. Hadley
Department of Pharmacy Practice and Pharmacy Administration, Philadelphia College of Pharmacy (PCP) at University of the Sciences (USciences), Philadelphia, USA
3 shared publications - Adriane N. Irwin
Oregon State University College of Pharmacy Corvallis Oregon USA
2 shared publications - Jamie C. Barner
Health Outcomes Division, College of Pharmacy The University of Texas at Austin Austin Texas USA
2 shared publications - Jane F. Bowen
Philadelphia College of Pharmacy, 600 S. 43rd Street, Philadelphia, PA 19104, United States
2 shared publications - Karen Nagel-Edwards
Midwestern University College of Pharmacy – Downers Grove Campus Downers Grove Illinois USA
2 shared publications - Karleen Melody
Department of Pharmacy Practice and Pharmacy Administration, Philadelphia College of Pharmacy, University of the Sciences, 600 S. 43rd Street, Philadelphia, PA 19104, United States
2 shared publications
Latest Publications
- 19 March 2025
- Published by Wiley in JACCP: Journal of the American College of Clinical Pharmacy
- Vol. 8 (4) , 271-280
Gender equity perceptions among pharmacy practice faculty in pharmacy academia
Introduction: Gender equity is desired in academia, including pharmacy education. Several studies in the past have demonstrated a lack of gender equity in academia, including a recent study among social and administrative sciences faculty in pharmacy schools.Objectives: The objective of this study was to determine whether perceptions of gender inequity exist among pharmacy practice faculty.Methods: Using a validated survey instrument, gender equity perceptions related to teaching, research, service, recruitment, mentoring, and advancement were measured on a three‐point Likert‐type scale. Respondents were also asked if they had experienced gender inequity and, if so, at what academic rank and which type of institution. A link to the survey was sent to 2567 pharmacy practice faculty who were members of the American Association of Colleges of Pharmacy and/or the American Pharmacists Association. Descriptive analysis, followed by chi‐square proportion comparisons, was conducted at 0.05 alpha.Results: Of the 155 eligible pharmacy faculty who responded to the survey, the majority were non‐Hispanic white women with a Doctor of Pharmacy degree. Gender inequity was reported by 64.7% of respondents and was associated with being women and with fewer years since their terminal degree. With regard to the three pillars of academia, women were more likely to perceive that men had more research resource allocations, less teaching and student success workload, more favorable teaching evaluation scores, and more favorable options for clinical and college service types. Similar perceptions were reported for recruitment, leadership opportunities, promotion and tenure, opportunities to be mentored, and respect from peers.Conclusion: Experiences of gender inequity as well as perceptions of gender inequity favoring men were found, particularly among women. This calls for the broader pharmacy practice community, as well as pharmacy academia leadership, to make intentional efforts to promote gender equity.
- 19 March 2025
- Published by Wiley in JACCP: Journal of the American College of Clinical Pharmacy
- Vol. 8 (4) , 271-280
Gender equity perceptions among pharmacy practice faculty in pharmacy academia
Introduction: Gender equity is desired in academia, including pharmacy education. Several studies in the past have demonstrated a lack of gender equity in academia, including a recent study among social and administrative sciences faculty in pharmacy schools.Objectives: The objective of this study was to determine whether perceptions of gender inequity exist among pharmacy practice faculty.Methods: Using a validated survey instrument, gender equity perceptions related to teaching, research, service, recruitment, mentoring, and advancement were measured on a three‐point Likert‐type scale. Respondents were also asked if they had experienced gender inequity and, if so, at what academic rank and which type of institution. A link to the survey was sent to 2567 pharmacy practice faculty who were members of the American Association of Colleges of Pharmacy and/or the American Pharmacists Association. Descriptive analysis, followed by chi‐square proportion comparisons, was conducted at 0.05 alpha.Results: Of the 155 eligible pharmacy faculty who responded to the survey, the majority were non‐Hispanic white women with a Doctor of Pharmacy degree. Gender inequity was reported by 64.7% of respondents and was associated with being women and with fewer years since their terminal degree. With regard to the three pillars of academia, women were more likely to perceive that men had more research resource allocations, less teaching and student success workload, more favorable teaching evaluation scores, and more favorable options for clinical and college service types. Similar perceptions were reported for recruitment, leadership opportunities, promotion and tenure, opportunities to be mentored, and respect from peers.Conclusion: Experiences of gender inequity as well as perceptions of gender inequity favoring men were found, particularly among women. This calls for the broader pharmacy practice community, as well as pharmacy academia leadership, to make intentional efforts to promote gender equity.
- 19 June 2023
- Published by Elsevier in American Journal of Pharmaceutical Education
- Vol. 87 (11) , 100546
The Intersection of Professional Identity Formation, Bias, and Marginalized Identities
- 19 June 2023
- Published by Elsevier in American Journal of Pharmaceutical Education
- Vol. 87 (11) , 100546
The Intersection of Professional Identity Formation, Bias, and Marginalized Identities
- 17 May 2022
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 63 (1) , 50-57.e2
Gender equity perceptions among social and administrative science faculty: A qualitative evaluation
- 17 May 2022
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 63 (1) , 50-57.e2
Gender equity perceptions among social and administrative science faculty: A qualitative evaluation
- Open Access
- 10 January 2022
- Published by Springer Nature in Journal of Cannabis Research
- Vol. 4 (1) , 1-6
Case report: Medical cannabis—warfarin drug-drug interaction
Aim: A case of an 85-year-old patient with concurrent use of warfarin and medical cannabis containing delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) is described. Warfarin continues to be a cornerstone of anticoagulation treatment despite the recent addition of FDA-approved anticoagulant agents. It is well known that warfarin has numerous drug interactions; however, much remains unknown about its interaction with THC and CBD. A literature review was conducted to identify documented cases of possible interactions between cannabis and warfarin. The case reports we identified noted that cannabis may potentially increase warfarin’s effect. Therefore, we aimed to determine why an effect was not seen on our patient’s warfarin dose despite daily use of medical cannabis. Case: This case report describes an 85-year-old patient who despite starting an oromucosal medical cannabis regimen of THC and CBD (which provided 0.3 mg of THC and 5.3 mg CBD once daily and an additional 0.625 mg of THC and 0.625 mg CBD once daily as needed) had minimal INR fluctuations from October 2018 to September 2019. Conclusion: Despite the introduction and use of medical cannabis therapy, with both THC and CBD components, an elderly patient with concurrent warfarin use did not see major INR fluctuations, in contrast to published literature. The potential for warfarin and THC/CBD interactions may be dependent on route of administration and dose of the cannabis product.
- 10 January 2022
- Published by Springer Nature in Journal of Cannabis Research
- Vol. 4 (1) , 1-6
Open AccessCase report: Medical cannabis—warfarin drug-drug interaction
Aim: A case of an 85-year-old patient with concurrent use of warfarin and medical cannabis containing delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) is described. Warfarin continues to be a cornerstone of anticoagulation treatment despite the recent addition of FDA-approved anticoagulant agents. It is well known that warfarin has numerous drug interactions; however, much remains unknown about its interaction with THC and CBD. A literature review was conducted to identify documented cases of possible interactions between cannabis and warfarin. The case reports we identified noted that cannabis may potentially increase warfarin’s effect. Therefore, we aimed to determine why an effect was not seen on our patient’s warfarin dose despite daily use of medical cannabis. Case: This case report describes an 85-year-old patient who despite starting an oromucosal medical cannabis regimen of THC and CBD (which provided 0.3 mg of THC and 5.3 mg CBD once daily and an additional 0.625 mg of THC and 0.625 mg CBD once daily as needed) had minimal INR fluctuations from October 2018 to September 2019. Conclusion: Despite the introduction and use of medical cannabis therapy, with both THC and CBD components, an elderly patient with concurrent warfarin use did not see major INR fluctuations, in contrast to published literature. The potential for warfarin and THC/CBD interactions may be dependent on route of administration and dose of the cannabis product.
- 1 January 2022
- Published by IGI Global Scientific Publishing
- p. 66-95
Creative Solutions for Today's Students
This chapter will explore the connection between diversifying health profession student demographics, diversifying challenges these students face, and the new obstacles presented by shifting curriculum delivery to remote and hybrid learning during the coronavirus disease 2019 (COVID-19) pandemic. The chapter will explore challenges that may seem especially difficult to address in a remote learning model: the desire to develop community among fellow learners when in a hybrid or fully remote program and when learners are from varied backgrounds; cultivating in students coping mechanisms to manage anxiety from the economic uncertainty of today's world, balancing commitments between educational pursuits and other responsibilities (e.g., child or parent care, etc.); and facilitating learning for students with physical and/or mental disabilities or chronic medical conditions.
- 1 January 2022
- Published by IGI Global Scientific Publishing
- p. 66-95
Creative Solutions for Today's Students
This chapter will explore the connection between diversifying health profession student demographics, diversifying challenges these students face, and the new obstacles presented by shifting curriculum delivery to remote and hybrid learning during the coronavirus disease 2019 (COVID-19) pandemic. The chapter will explore challenges that may seem especially difficult to address in a remote learning model: the desire to develop community among fellow learners when in a hybrid or fully remote program and when learners are from varied backgrounds; cultivating in students coping mechanisms to manage anxiety from the economic uncertainty of today's world, balancing commitments between educational pursuits and other responsibilities (e.g., child or parent care, etc.); and facilitating learning for students with physical and/or mental disabilities or chronic medical conditions.
- Open Access
- 1 September 2014
- Published by SciELO Espana/Repisalud in Pharmacy Practice
- Vol. 12 (3)
Pharmacists implementing transitions of care in inpatient, ambulatory and community practice settings [UPDATED]
To introduce pharmacists to the process, challenges, and opportunities of creating transitions of care (TOC) models in the inpatient, ambulatory, and community practice settings. TOC literature and resources were obtained through searching PubMed, Ovid, and GoogleScholar. The pharmacist clinicians, who are the authors in this manuscript are reporting their experiences in the development, implementation of, and practice within the TOC models. Pharmacists are an essential part of the multidisciplinary team and play a key role in providing care to patients as they move between health care settings or from a health care setting to home. Pharmacists can participate in many aspects of the inpatient, ambulatory care, and community pharmacy practice settings to implement and ensure optimal TOC processes. This article describes establishing the pharmacist’s TOC role and practicing within multiple health care settings. In these models, pharmacists focus on medication reconciliation, discharge counseling, and optimization of medications.[a sentence was deleted] Optimizing the TOC process, reducing medication errors, and preventing adverse events are important focus areas in the current health care system, as emphasized by The Joint Commission and other health care organizations. Pharmacists have the unique opportunity and skillset to develop and participate in TOC processes that will enhance medication safety and improve patient care.
- 1 September 2014
- Published by SciELO Espana/Repisalud in Pharmacy Practice
- Vol. 12 (3)
Open AccessPharmacists implementing transitions of care in inpatient, ambulatory and community practice settings [UPDATED]
To introduce pharmacists to the process, challenges, and opportunities of creating transitions of care (TOC) models in the inpatient, ambulatory, and community practice settings. TOC literature and resources were obtained through searching PubMed, Ovid, and GoogleScholar. The pharmacist clinicians, who are the authors in this manuscript are reporting their experiences in the development, implementation of, and practice within the TOC models. Pharmacists are an essential part of the multidisciplinary team and play a key role in providing care to patients as they move between health care settings or from a health care setting to home. Pharmacists can participate in many aspects of the inpatient, ambulatory care, and community pharmacy practice settings to implement and ensure optimal TOC processes. This article describes establishing the pharmacist’s TOC role and practicing within multiple health care settings. In these models, pharmacists focus on medication reconciliation, discharge counseling, and optimization of medications.[a sentence was deleted] Optimizing the TOC process, reducing medication errors, and preventing adverse events are important focus areas in the current health care system, as emphasized by The Joint Commission and other health care organizations. Pharmacists have the unique opportunity and skillset to develop and participate in TOC processes that will enhance medication safety and improve patient care.
- Open Access
- 1 June 2014
- Published by SciELO Espana/Repisalud in Pharmacy Practice
- Vol. 12 (2) , 439
Pharmacists implementing transitions of care in inpatient, ambulatory and community practice settings
To introduce pharmacists to the process, challenges, and opportunities of creating transitions of care (TOC) models in the inpatient, ambulatory, and community practice settings. TOC literature and resources were obtained through searching PubMed, Ovid, and GoogleScholar. The pharmacist clinicians, who are the authors in this manuscript are reporting their experiences in the development, implementation of, and practice within the TOC models. Pharmacists are an essential part of the multidisciplinary team and play a key role in providing care to patients as they move between health care settings or from a health care setting to home. Pharmacists can participate in many aspects of the inpatient, ambulatory care, and community pharmacy practice settings to implement and ensure optimal TOC processes. This article describes establishing the pharmacist’s TOC role and practicing within multiple health care settings. In these models, pharmacists focus on medication reconciliation, discharge counseling, and optimization of medications. Additionally, a checklist has been created to assist other pharmacists in developing the pharmacist’s TOC roles in a practice environment or incorporating more TOC elements in their practice setting. Optimizing the TOC process, reducing medication errors, and preventing adverse events are important focus areas in the current health care system, as emphasized by The Joint Commission and other health care organizations. Pharmacists have the unique opportunity and skillset to develop and participate in TOC processes that will enhance medication safety and improve patient care.
- 1 June 2014
- Published by SciELO Espana/Repisalud in Pharmacy Practice
- Vol. 12 (2) , 439
Open AccessPharmacists implementing transitions of care in inpatient, ambulatory and community practice settings
To introduce pharmacists to the process, challenges, and opportunities of creating transitions of care (TOC) models in the inpatient, ambulatory, and community practice settings. TOC literature and resources were obtained through searching PubMed, Ovid, and GoogleScholar. The pharmacist clinicians, who are the authors in this manuscript are reporting their experiences in the development, implementation of, and practice within the TOC models. Pharmacists are an essential part of the multidisciplinary team and play a key role in providing care to patients as they move between health care settings or from a health care setting to home. Pharmacists can participate in many aspects of the inpatient, ambulatory care, and community pharmacy practice settings to implement and ensure optimal TOC processes. This article describes establishing the pharmacist’s TOC role and practicing within multiple health care settings. In these models, pharmacists focus on medication reconciliation, discharge counseling, and optimization of medications. Additionally, a checklist has been created to assist other pharmacists in developing the pharmacist’s TOC roles in a practice environment or incorporating more TOC elements in their practice setting. Optimizing the TOC process, reducing medication errors, and preventing adverse events are important focus areas in the current health care system, as emphasized by The Joint Commission and other health care organizations. Pharmacists have the unique opportunity and skillset to develop and participate in TOC processes that will enhance medication safety and improve patient care.
- 1 January 2013
- Published by Elsevier in Clinical Therapeutics
- Vol. 35 (1) , 4-27
Rivaroxaban: An Oral Factor Xa Inhibitor
- 1 January 2013
- Published by Elsevier in Clinical Therapeutics
- Vol. 35 (1) , 4-27
Rivaroxaban: An Oral Factor Xa Inhibitor